New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.


  • R01 Deadlines: Feb. 5, Jun. 5, Oct. 5.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7

PAS-21-150 Expiration Date: May 08, 2024

Agency Website

Eligibility Requirements

In light of the short duration of this R01, Early Stage Investigators (ESI) and New Investigators (NI) are strongly encouraged to consult with a Scientific/Research Contact prior to submission.



Amount Description

Application budgets should reflect the actual needs of the proposed project and should be limited to no more than $200,000 in direct costs per year.

The scope of the proposed project should determine the project period. The maximum project period is three years.

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

February 5, 2024